Detalhe da pesquisa
1.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324483
2.
Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity.
JAMA
; 324(1): 33-34, 2020 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463422
3.
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial.
Nat Med
; 29(11): 2919-2928, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845512
4.
Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558277
5.
Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.
J Clin Psychopharmacol
; 22(6): 592-8, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12454559